Core Insights - Colgate-Palmolive reported quarterly earnings of $0.91 per share, exceeding the Zacks Consensus Estimate of $0.89 per share, with an earnings surprise of +2.25% [1] - The company posted revenues of $5.13 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.07%, but showing a year-over-year increase from $5.03 billion [2] - The stock has underperformed the market, losing about 15.8% year-to-date compared to the S&P 500's gain of 16% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.94, with expected revenues of $5.15 billion, and for the current fiscal year, the EPS estimate is $3.67 on revenues of $20.31 billion [7] - The estimate revisions trend for Colgate-Palmolive was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Consumer Products - Staples industry, to which Colgate-Palmolive belongs, is currently ranked in the bottom 17% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]
Colgate-Palmolive (CL) Surpasses Q3 Earnings Estimates